Demecolcine: Difference between revisions
(Created page with "<div style="float: right;"> thumb|none|400px|This image is provided by the National Library of Medicine.</div> __NOTOC__ {{SI}} {{CMG}} ==Overview=...") |
m (Protected "Demecolcine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Demecolcine.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Demecolcine.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 22: | Line 19: | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Ketones]] | [[Category:Ketones]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 19:40, 18 August 2015
|
WikiDoc Resources for Demecolcine |
|
Articles |
|---|
|
Most recent articles on Demecolcine Most cited articles on Demecolcine |
|
Media |
|
Powerpoint slides on Demecolcine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Demecolcine at Clinical Trials.gov Clinical Trials on Demecolcine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Demecolcine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Demecolcine Discussion groups on Demecolcine Patient Handouts on Demecolcine Directions to Hospitals Treating Demecolcine Risk calculators and risk factors for Demecolcine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Demecolcine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demecolcine, also known as colcemid, is a drug used in chemotherapy.It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic. It depolymerises microtubules and limits microtubule formation (inactivates spindle fibre formation), thus arresting cells in metaphase and allowing cell harvest and karyotyping to be performed.
During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.[1] In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.[2]
Mechanism of Action
Demecolcine is a microtubule-depolymerizing drug like vinblastine. It acts by two distinct mechanisms. At very low concentration it binds to microtubule plus end to suppress microtubule dynamics.[3] Recent study has found at higher concentration colcemid can promote microtubule detachment from microtubule organizing center. Detached microtubules with unprotected minus end depolymerizes with time. Cytotoxicity of the cells seems to correlate better with microtubule detachment.[4] Lower concentration affects microtubule dynamics and cell migration.[4]
References
- ↑ Brit med J., 1965, 1, 495 – 496
- ↑ Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26
- ↑ Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature reviews. Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID 15057285.
- ↑ 4.0 4.1 Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando (2010). "Inhibition of cell migration and cell division correlate with distinct effects of microtubule inhibiting drugs". The Journal of Biological Chemistry. 285 (42): 32242–50. doi:10.1074/jbc.M110.160820. PMC 2952225. PMID 20696757.